Thomas Parzefall

7PUBLICATIONS
31CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)NeurogeneticsDisease surveillanceGene mappingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2024
Mutational spectrum in patients with dominant non-syndromic hearing loss in Austria.

Alexandra Frohne, Sybille Vrabel, Franco Laccone

|Nov 29, 2022
A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation.

Alexandra Frohne, Martin Koenighofer, Hakan Cetin

|Jun 29, 2021
Biannual Differences in Interest Peaks for Web Inquiries Into Ear Pain and Ear Drops: Infodemiology Study.

Faris F Brkic, Gerold Besser, Martin Schally

|Apr 14, 2021
Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma.

Martin Koenighofer, Thomas Parzefall, Alexandra Frohne

|Oct 30, 2019
Lymph node ratio as a prognostic marker in advanced laryngeal and hypopharyngeal carcinoma after primary total laryngopharyngectomy.

Stefan Grasl, Stefan Janik, Thomas Parzefall

|Jan 08, 2019
Dysregulation of ß-catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck.

Erich Vyskocil, Johannes Pammer, Gabriela Altorjai

Pageof 2